Preliminary programme
5th Central European Biomedical Congress, Kraków, Poland,
May 29 – June 1, 2023, Future trends in health interventions
Venue: Auditorium Maximum, 33 Krupnicza Street, Krakow, Poland
Sessions
| Monday, May 29, 2023 | |
| 8.00 a.m. – 5.00 p.m. | Registration |
| 9.30 – 10.30 a.m. – Large Hall | Plenary lecture |
| Professor Gustavo Turecki PhD, MD | |
| Douglas Hospital Research Centre, McGill Group for Suicide Studies, Montreal, Quebec, Canada | |
| Chair persons: Professor Marta Dziedzicka-Wasylewska, PhD; Agata Faron Górecka, PhD | |
| TBA | |
| 10.30 – 11.00 a.m. – Exhibition Room | Coffee break |
| 11.00 – 12.30 p.m. – Medium Hall A | Session 1: Blood-brain barrier dysfunction in CNS disorders |
| Chair persons: Professor Marta Dziedzicka-Wasylewska, PhD, Agata Faron Górecka, PhD | |
| S. 01-1 | |
| Professor Marta Dziedzicka-Wasylewska, PhD | |
| Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland | |
| Potential role of blood-brain barrier in stress resilience | |
| S. 01-2 | |
| Agnieszka Chocyk, PhD | |
| Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland | |
| Sex-specific effects of early-life stress on blood-brain barrier function and response to immune challenge in rats | |
| S. 01-3 | |
| Barbara Błasiak, PhD | |
| Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland | |
| MRI Contrast Agents Crossing Blood-Brain Barrier | |
| 11.00 – 12.30 p.m. – Medium Hall B | Session 2: Mass spectrometry in medical sciences |
| Chair person: Przemysław Mielczarek, PhD | |
| S. 02-1 | |
| Professor Giuseppe Grasso, PhD | |
| University of Catania, Catania, Italy | |
| TBA | |
| S. 02-2 | |
| Professor Vladimir Havlicek, PhD | |
| Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic | |
| Next generation infection diagnostics | |
| S. 02-3 | |
| Professor Anna Bodzon-Kulakowska, PhD | |
| AGH University of Science and Technology, Krakow, Poland | |
| TBA | |
| S. 02-4 | |
| Joanna Kasprzyk-Pochopień, M.Sc | |
| JagiellonianUniversity, Krakow, Poland | |
| TBA | |
| 12.30 – 1.00 p.m. – Medium Hall A, B | Sponsor presentation |
| 1.00 – 2.30 p.m. – Medium Hall A | Session 3: Theranostic nanocarriers for drug delivery in central nervous system disorders |
| Chair persons: Professor Władysław Lasoń, PhD; Professor Piotr Warszyński, PhD | |
| S. 03-1 | |
| Juan Yang, PhD | |
| Functional Ceramics and Nanomaterials, SINTEF, Oslo, Norway | |
| Progress of Engineered nanoparticls as theranostic nanocarriers | |
| S. 03-2 | |
| Krzysztof Szczepanowicz , PhD | |
| Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Krakow, Poland | |
| Synthesis and characterization of polymer-based theranostic nanoparticles containing carnosic acid | |
| S. 03-3 | |
| Danuta Jantas, PhD | |
| Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland | |
| Biosafety and neuroprotective potency of polymer-based theranostic nanoparticles containing carnosic acid | |
| S. 03-4 | |
| Rugmani Meenambal, PhD | |
| Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland | |
| Polyacrylic acid (PAA) conjugated cerium oxide nanoparticles as efficient neuroprotectants against oxidative stress-induced cell damage in human neuronal-like cells | |
| 1.00 – 2.30 p.m. – Medium Hall B | Session 4: Modern approaches in immunodiagnostics and immunotherapy |
| Chair person: Professor Maciej Siedlar, PhD | |
| TBA | |
| S. 04-1 | |
| Professor Maciej Siedlar, PhD | |
| Institute of Paediatrics, Jagiellonian University Medical College, Kraków, Poland | |
| TBA | |
| S. 04-2 | |
| Proffessor Marcin Majka, PhD | |
| Institute of Paediatrics, Jagiellonian University Medical College, Kraków, Poland | |
| Future of cell-based therapeutics in the light of today’s developments. | |
| S. 04-3 | |
| Professor Gabriela Kania, PhD | |
| University of Zurich, Center of Experimental Theumatology, Zurich, Switzerland | |
| Tale of two tubes exploring pathological mechanisms in systemic sclerosis – focus on monocytes and macrophages | |
| 2.30 – 3.00 p.m. – Exhibition Room | Coffee break |
| 3.00 – 3.15 p.m. – Large Hall | Welcome ceremony |
| Chair persons: Honorary Committee & Organizing Committee | |
| 3.15 – 4.15 p.m. | Inaugural lecture |
| Professor Véronique Deroche-Gamonet PhD, HDR | |
| Université de Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France | |
| Chair person: Jan Rodriguez-Parkitna, PhD | |
| TBA | |
| 4.15 – 4.30 p.m. | Promotion of the city of Krakow and the Maj Institute of Pharmacology Polish Academy of Sciences – Large hall |
| 4.30 – 5.30 p.m. – Large Hall | Music performance |
| 5.30 – 9.00 p.m. – Exhibition Room | Welcome party |
| Tuesday, 30 May 2023 | |
| 9.00 – 10.30 a.m. – Medium Hall A | Session 5: The burden of neurodegenerative and psychiatric disorders: trends and future treatment |
| Chair person: Professor Katarzyna Starowicz – Bubak, PhD | |
| S. 05-1 | |
| Professor Aron H. Lichtman, PhD | |
| Virginia Commonwealth University, Richmond, VA, USA | |
| TBA | |
| S. 05-2 | |
| Professor Danilo De Gregorio, PhD | |
| Vita-Salute University and San Raffaele Scientific Institute, Milan, Italy | |
| Therapeutic use of psychedelics in mental health | |
| S. 05-3 | |
| Iskra Pollak Dorocic | |
| Stockholm University, Stockholm, Sweeden | |
| Transcriptional effects of SSRI administration on brain networks | |
| 9.00 – 10.30 a.m. – Medium Hall B | Session 6: Sphingolipids in health and brain diseases |
| Chair persons: Professor Christian P. Muller, PhD; Małgorzata Frankowska, PhD | |
| S. 06-1 | |
| Professor Christian P. Muller, PhD | |
| Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany | |
| Sphingolipids in the brain: from memory control to psychiatric disorders | |
| S. 06-2 | |
| Alessandro Prinetti, PhD | |
| University of Milano, Italy | |
| Sphingolipids orchestrating the cross-talk between different cell populations in the formation of myelin and in the repair of damaged myelin | |
| S. 06-3 | |
| Vittorio Maglione, PhD | |
| Neuromed, Pozzilli, Italy | |
| Sphingolipid alterations in Huntington’s disease: new insights into molecular mechanisms and potential therapies | |
| 10.30 – 11.00 a.m. – Medium Hall A, B | Sponsor presentation |
| 11.00 – 11.30 a.m. – Exhibition Room | Coffee break |
| 11.30 – 12.30 p.m. – Medium Hall | Plenary lecture |
| Professor Johannes Kornhuber, PhD, MD | |
| Friedrich-Alexander-Universität Erlangen-Nürnberg University Hospital, Erlangen, Germany | |
| Chair person: Professor Małgorzata Filip, PhD, Professor Joanna Pera, PhD | |
| TBA | |
| 12.30 – 1.30 p.m. – Exhibition Room | Poster session 1 |
| Lunch break | |
| 1.30 – 3.00 p.m. – Medium Hall A | Session 7: Digital medicine – beyond diagnostics |
| Chair person: Klaudia Proniewska, PhD | |
| S. 07-1 | |
| Klaudia Proniewska, PhD | |
| Jagiellonian University Medical College, Krakow, Poland | |
| TBA | |
| S. 07-2 | |
| Danila Potyagaylo | |
| EPIQure GmbH, Nuremberg, Germany | |
| Combination of 12-lead ECG with patient-specific anatomical data for personalized cardiology and electrophysiology | |
| S. 07-3 | |
| Peter van Dam | |
| TBA | |
| TBA | |
| 1.30 – 3.00 p.m. – Medium Hall B | Session 8: New targets, new ligands, new drugs: a novel approach for the treatment of the CNS pathologies |
| Chair persons: Professor Małgorzata Kajta, PhD; Agnieszka Wnuk, PhD | |
| S. 08-1 | |
| Adib Zendedel, PhD | |
| Institute of Neuroanatomy, Medical Faculty, RWTH Aachen University, Aachen, Germany | |
| The role of microglial-derived extracellular vesicles in the pathogenesis of traumatic spinal cord injury: implication of exosomal microRNAs | |
| S. 08-2 | |
| Professor Joanna Śliwowska, PhD | |
| Poznań University of Life Sciences, Poznań, Poland | |
| Metabolic and reproductive dysfunctions associated with obesity and diabetes: From the womb to adulthood | |
| S. 08-3 | |
| Agnieszka Wnuk, PhD | |
| Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland | |
| Emerging evidence for triclocarban as a neurodevelopmental risk factor: disruption of epigenetic status and dysregulation of neurogenesis-related genes. | |
| S. 08-4 | |
| Professor Małgorzata Kajta, PhD | |
| Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland | |
| New treatment strategies against neural degenerations based on selective targeting of membrane estrogen receptors and PPARγ | |
| 3.00 – 3.30 p.m. – Exhibition Room | Coffee break |
| 3.30 – 5.00 p.m. – Medium Hall A | Session 9: Chaperons in Gaucher’s disease |
| Chair person: Professor Beata Kieć-Wilk, PhD | |
| S. 09-1 | |
| TBA | |
| TBA | |
| TBA | |
| S. 09-2 | |
| TBA | |
| TBA | |
| TBA | |
| S. 09-3 | |
| TBA | |
| TBA | |
| TBA | |
| 3.30 – 5.00 p.m. – Medium Hall B | Session 10: Tracking brain projections and cell signaling involved in neuroadaptations triggered by cocaine, stress, or neurodegeneration |
| Chair persons: Grzegorz Kreiner, PhD; Agnieszka Zelek-Molik, PhD | |
| S. 10-1 | |
| Rachel J. Smith, PhD | |
| Texas A&M University, USA | |
| Investigating the link between habitual cocaine seeking and punishment resistance in rat models of addiction | |
| S. 10-2 | |
| Yonatan Kupchik | |
| The Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Israel | |
| Multimodal differences between projections of the ventral pallidum and relevance to cocaine reward | |
| S. 10-3 | |
| Agnieszka Zelek-Molik, PhD | |
| Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków | |
| Psychosocial crowding stress affects neuroplasticity-related signalling pathways within rats’ frontal cortex in a region-dependent manner | |
| S.10-4 | |
| Justyna Barut, MSc | |
| Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków | |
| Utilization of conditional single lentivirus CRISPR/Cas9 vector for efficient gene knockout generation in adult neurons in vivo and in vitro as potential new model for study prodromal phase of Parkinson’s disease | |
| Wednesday, 31 May 2023 | |
| 9.00 – 10.30 a.m. – Medium Hall A | Session 11: Medical biotechnology in disease modelling, drug research and therapy |
| Chair person: Professor Józef Dulak, PhD | |
| S. 11-1 | |
| Professor Józef Dulak, PhD; Professor Agnieszka Łoboda, PhD | |
| Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland | |
| Stem cells in neurological diseases modelling and therapies: possibilities, hopes and hypes. | |
| S. 11-2 | |
| Florence Rage, PhD | |
| Institute de Genetique Moleculaire, CNRS, Montpellier, France | |
| Human NMJ: from a single chip to a Simplified Miniature Array (SMA) for drugs screening | |
| S. 11-3 | |
| Sifeng Chen, PhD | |
| Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of China | |
| The therapeutic effects of induced pluripotent stem cells and their exosomes on cardiovascular diseases | |
| 9.00 – 10.30 a.m. – Medium Hall B | Session 12: Novel rapid-acting antidepressants |
| Chair persons: Bernadeta Szewczyk, PhD; Professor Andrzej Pilc, PhD | |
| S. 12-1 | |
| Professor Jeffrey M Witkin, PhD | |
| University of Wisconsin – Milwaukee, USA | |
| New age antidepressants create new ways to think about treatment | |
| S. 12-2 | |
| Professor Laura Musazzi, PhD | |
| School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy | |
| Molecular signature of ketamine – response/non-response in a preclinical model of depression | |
| S. 12-3 | |
| Professor Shigeyuki Chaki, PhD | |
| Taisho Pharmaceutical, Japan | |
| Ketamine-like antidepressant potential of mGlu2/3 receptor antagonists and progress of other candidates targeting the glutamatergic system |
|
| 10.30 – 11.00 a.m. – Medium Hall A, B | Sponsor presentation |
| 11.00 – 11.30 a.m. – Exhibition Room | Coffee break |
| 11.30 – 12.30 p.m. – Medium Hall | Plenary lecture |
| Professsor Stefan Chłopicki, PhD, MD | |
| Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland | |
| Chair person: Professor Małgorzata Filip, PhD | |
| TBA | |
| 12.30 – 1.30 p.m. – Exhibition Room | Poster session 2 |
| Lunch break | |
| 1.30 – 3.00 p.m. – Medium Hall A | Session 13: Innovative nanocarriers and treatment modalities in antitumor therapy |
| Chair person: Professor Bożena Kaczmarek, PhD | |
| S. 13-1 | |
| Professor Bożena Kamińska-Kaczmarek, PhD | |
| Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland | |
| Reinvigorating antitumor immunity in brain tumors with short peptides and siRNA-nanocarriers targeting the tumor microenvironment | |
| S. 13-2 | |
| Professor Ling Peng, PhD | |
| Aix-Marseille University, Marseille, France | |
| Modular and adaptive dendrimer nanosystems in cancer treatment | |
| S. 13-3 | |
| Professor Tambet Tessalu, PhD | |
| University of Tartu, Tartu, Estonia | |
| Targeting of nanoparticles with homing peptides | |
| 1.30 – 3.00 p.m. – Medium Hall B | Session 14: Duchenne muscular dystrophy and its complications – new tools and mechanisms for possible treatments |
| Chair persons: Professor Agnieszka Łoboda, PhD | |
| S. 14-1 | |
| Maurilio Sampaolesi | |
| KU Leuven, Leuven, Belgium | |
| Harnessing novel 3D stem cell-based models to challenge dystrophic cardiomyopathy | |
| S. 14-2 | |
| Jacek Stępniewski | |
| Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland | |
| Human induced pluripotent stem cells and gene editing for modelling of Duchenne muscular dystrophy-associated cardiomyopathy | |
| S. 14-3 | |
| Professor Agnieszka Łoboda, PhD | |
| Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland | |
| Hydrogen sulfide donors: therapeutic potential in Duchenne muscular dystrophy | |
| 3.00 – 3.30 p.m. – Exhibition Room | Coffee break |
| 3.30 – 5.00 p.m. – Medium Hall A | Session 15: Future therapies with psychodelics |
| Chair person: Professor Krystyna Gołembiowska, PhD | |
| S. 15-1 | |
| Professor Charles Nichols, PhD | |
| LSU Health Sciences Center, New Orleans, LA, US | |
| A single treatment with psychedelics can produce persistent antidepressant-like effects, and changes in functional plasticity across several types of depression models in both rats and fruit flies | |
| S. 15-2 | |
| Urszula Kozłowska | |
| Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland | |
| Psychedelics immunomodulatory effect on microglia and its prospect meaning for neurodegenerative diseases treatment. | |
| 5.00 – 6.00 p.m. – Seminar Room, Conference Room | Workshop |
| CEPHARES – a new R&D division of Maj Institute of Pharmacology. Mission, opportunities, perspectives | |
| TBA | |
| 8.00 – 11.00 p.m. | Congress dinner – Kościuszko Mound in Kraków, 1 Washington Avenue |
| Thursday, 1 June 2023 | |
| 9.00 – 10.00 a.m. – Large Hall | Plenary lecture |
| Professor Kathryn A. Cunningham, PhD | |
| The University of Texas Medical Branch at Galveston, USA | |
| Chair person: Professor Małgorzata Filip, PhD | |
| TBA | |
| 10.00 – 10.30 a.m. – Exhibition Room | Coffee break |
| 10.30 – 12.00 a.m. – Large Hall | Session 16: Magnificent Seven: on the role of the 5-HT7R receptor in the brain |
| Chair person: Monika Bijata, PhD, Professor Paweł Zajdel, PhD | |
| S. 16-1 | |
| Morisset-Lopez | |
| Molecular Biophysics Center, The University of Orléans, INSERM, France | |
| Discovery of biased ligands of 5-HT7R to illuminate the receptor biology | |
| S. 16-2 | |
| Professor Evgeni Ponimaskin, PhD | |
| Hannover Medical School, Hannover, Germany | |
| Targeting the serotonin receptor 7 (5-HT7R) ameliorates Tau pathology and memory deficits | |
| S. 16-3 | |
| Jakub Włodarczyk, PhD | |
| Nencki Institute of Experimental Biology of Polish Academy of Science, Warsaw, Poland | |
| The molecular fingerprint of stress resilience | |
| 12.00 -12.30 p.m. | Lunch break – Exhibition Room |
| 12.30 a.m. – 1.30 p.m. – Medium Hall | Plenary lecture |
| Professor Stéphane Oliet, PhD | |
| Bordeaux Neurocampus, University de Bordeaux, France | |
| Chair person: Professor Joanna Pera, MD, PhD | |
| TBA | |
| 1.30 – 2.45 p.m. | Session 17: |
| Young scientific investigators’ session | |
| 75 min, Medium Hall | |
| Chair person: Professor Rafał Ryguła, PhD | |
| 2.45 – 3.15 p.m. | Closing & Award ceremony – Medium Hall |
| Chair persons: Professor Małgorzata Filip, PhD, Professor Joanna Pera, PhD | |